or Try an Advanced Search...

    Clinical Trial Product Stocks List

    Symbol Grade Name % Change
    INCY A Incyte Corporation 2.71
    LBPH A Longboard Pharmaceuticals, Inc. -0.05
    LGND A Ligand Pharmaceuticals Incorporated 4.11
    SUPN B Supernus Pharmaceuticals, Inc. -0.29
    HALO B Halozyme Therapeutics, Inc. 13.01
    HCM C Hutchison China MediTech Limited 3.50
    BIIB F Biogen Idec Inc. -0.12
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

    Symbol Grade Name Weight
    IBRN B iShares Neuroscience and Healthcare ETF 10.01
    PBE C PowerShares Dynamic Biotech & Genome 9.96
    FBT A First Trust Amex Biotech Index Fund 9.88
    PJP C PowerShares Dynamic Pharmaceuticals 9.65
    BIS C ProShares UltraShort Nasdaq Biotechnology 9.05
    View all Clinical Trial Product ETFs...
    Compare ETFs
    Compare IBRN to FBT Compare PBE to FBT Compare PBE to PJP

        Clinical Trial Product Stocks Recent News

        Date Stock Title
        Nov 2 INCY What Moved Markets This Week
        Nov 1 HALO Top High Growth Tech Stocks To Watch In November 2024
        Nov 1 HALO Halozyme Announces Record Earnings, Guidance
        Nov 1 HALO HALO Beats Q3 Earnings & Sales Estimates, Raises '24 View, Stock Up
        Nov 1 HALO Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
        Nov 1 BIIB Biogen partner Eisai completes FDA submissions for injectable Alzheimer’s therapy
        Nov 1 LGND Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston
        Nov 1 BIIB Biogen Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 1 HALO Halozyme Therapeutics Inc (HALO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
        Oct 31 HALO Halozyme Therapeutics, Inc. (HALO) Q3 2024 Earnings Call Transcript
        Oct 31 HALO Halozyme Therapeutics, Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 31 BIIB Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter
        Oct 31 HALO Halozyme Therapeutics (HALO) Reports Q3 Earnings: What Key Metrics Have to Say
        Oct 31 HALO Halozyme Therapeutics (HALO) Beats Q3 Earnings and Revenue Estimates
        Oct 31 HALO Halozyme Therapeutics: Q3 Earnings Snapshot
        Oct 31 SUPN Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024
        Oct 31 HALO Halozyme Therapeutics Non-GAAP EPS of $1.27 beats by $0.27, revenue of $290.1M beats by $37.93M
        Oct 31 HALO HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS
        Oct 31 BIIB Biogen down as Morgan Stanley cuts rating on sluggish Alzheimer’s drug launch
        Oct 31 BIIB Biogen slips as Morgan Stanley downgrades on Leqembi launch
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis
        Clinical Trial Product

        Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.

        Browse All Tags